Discovery of pancreatic tumor vulnerability could pave the way for new treatments

A team from the Research Institute of the McGill University Health Center (The Institute), led by Jean-Jacques Lebrun, Ph.D., has identified a protein that pancreatic cancer cells rely on to survive and grow. This discovery opens a promising avenue for the research and development of more effective and targeted therapies to treat one of the most aggressive and deadly cancers.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup